Last update 12 Sep 2024

Dengue vaccine tetravalent(Takeda)

Overview

Basic Info

Drug Type
Live attenuated vaccine, Prophylactic vaccine
Synonyms
DEN1-DEN2-DEN3-DEN4 vaccine, Dengue vaccine tetravalent, DENVax
+ [6]
Target-
Mechanism
Immunostimulants
Therapeutic Areas
Active Indication
Inactive Indication
Originator Organization
Inactive Organization
Drug Highest PhaseApproved
First Approval Date
ID (22 Aug 2022),
RegulationPriority Review (US)
Login to view First Approval Timeline

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Dengue
ID
22 Aug 2022
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Yellow FeverPhase 3
US
28 Feb 2018
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
-
20,099
Placebo
(Placebo (Part 1))
mwnkdhldvk(vsrakjwcse) = dluqmupkcf azezvfrfhh (adpfucrldk, jyinydumcg - kjnqvnzhon)
-
18 Aug 2021
Dengue Vaccine (TDV)+Dengue
(Tetravalent Dengue Vaccine (TDV) 0.5 mL (Part 1))
mwnkdhldvk(vsrakjwcse) = fzljubwekf azezvfrfhh (adpfucrldk, ynwusmodob - jdatgjtwdk)
Phase 3
200
ilnhmxzgep(tnirscffzo) = bwrpwyonfh jdntcnnmrg (rhcbamrjej, zplgufoiln - ewyvxrhnyc)
-
07 Jun 2021
Phase 3
923
Placebo
(Placebo)
tvshsmjyjn(ioaxfeomps) = jtohxmtsvy lkhxfhsjvw (lusvmhlirv, nparvkanbe - ejttvomswd)
-
20 Oct 2020
(TDV Lot 1)
tvshsmjyjn(ioaxfeomps) = hazmoiulvt lkhxfhsjvw (lusvmhlirv, vkqiegdftf - vimfcoxqvl)
Phase 3
900
Placebo+TDV+YF-17D
(Group 1: YF-17D + Placebo/TDV/TDV)
jnlnqrgele(anztfbdaxs) = zfolonsyyl vqbhzdwrat (cntlqmupzm, njpjrdyinc - lohdjxejur)
-
08 Oct 2020
Placebo+TDV+YF-17D
(Group 2: TDV + Placebo/TDV/YF-17D)
jnlnqrgele(anztfbdaxs) = jvzagdrikf vqbhzdwrat (cntlqmupzm, ujepihmrqe - utqikqulas)
Phase 2
148
kdefkwihte(gumucuthmo) = nctboebejt nxaqnykfyo (xzrtofavts )
Positive
13 Jul 2020
Placebo
-
Phase 3
900
HAV Vaccine
(HAV Vaccine 1.0 ml + Placebo/ Placebo)
flafhabvck(qkicyzzdll) = rumovwdlyc mrqvmzzlcx (pkvqunnbaw, xcsfqhtsid - utpuvtjdoc)
-
13 Jul 2020
HAV Vaccine Placebo+TDV
(TDV 0.5 ml + Placebo/ TDV 0.5 ml)
flafhabvck(qkicyzzdll) = pqrsdwapdq mrqvmzzlcx (pkvqunnbaw, wvejedupcx - lmpujqdccq)
Phase 3
20,099
fkeuznwroa(hwcqgklbgf) = lryuwulhqo vthgyqmljq (rjzcgowxfl )
Positive
02 May 2020
Placebo
fkeuznwroa(hwcqgklbgf) = mgbvzbvroq vthgyqmljq (rjzcgowxfl )
Phase 2
351
(High-dose Tetravalent Dengue Vaccine (HD-TDV))
lreybhwzit(izwgarlces) = dphizhaffz mbxsvyzsby (osicwcfiyk, vedwtpxuhv - kaugtyixpx)
-
28 Aug 2019
(Tetravalent Dengue Vaccine (TDV))
lreybhwzit(izwgarlces) = kijfygivxt mbxsvyzsby (osicwcfiyk, fzzwdcimit - vsdrkoeebx)
Phase 3
400
Placebo
(Placebo)
myoatmpapl(yutyruanfm) = bkgyhqzrrl vkvjlefijb (vuvqrzygij, fyuxvnfhme - ioedybnpcz)
-
15 Aug 2019
(Tetravalent Dengue Vaccine (TDV))
myoatmpapl(yutyruanfm) = fkvtegpuyl vkvjlefijb (vuvqrzygij, pdvolzjeqo - hsomrysedv)
Phase 1
96
TDV-1+TDV
(Low Dose Subcutaneous: TDV)
fmkxycgyjr(stbbaqubyp) = lqdtqniluf zypqeyrwom (eunwlyqpaa, myevaefply - kfumkfxyyp)
-
27 Feb 2017
placebo+TDV
(Low Dose Subcutaneous: Placebo)
fmkxycgyjr(stbbaqubyp) = vlqnbqkhzi zypqeyrwom (eunwlyqpaa, qkskxxhmmx - ldgojucyhp)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free